Business Description
Beijing Luzhu Biotechnology Co Ltd
ISIN : CNE100005YD8
Share Class Description:
HKSE:02480: H shareCompare
Compare
Traded in other countries / regions
02480.Hong Kong IPO Date
2023-05-05Description
Beijing Luzhu Biotechnology Co Ltd is a biotechnology company committed to developing innovative human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. Its clinical-stage product candidates comprise one vaccine candidate, LZ901 and two antibody injection product candidates, including K3 and K193. LZ901 is our Core Product.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 31.66 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.01 | |||||
| 9-Day RSI | 94.04 | |||||
| 14-Day RSI | 84.3 | |||||
| 6-1 Month Momentum % | -46.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.45 | |||||
| Quick Ratio | 6.41 | |||||
| Cash Ratio | 6.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -23.9 | |||||
| ROA % | -21.31 | |||||
| ROIC % | -47.36 | |||||
| ROC (Joel Greenblatt) % | -60.11 | |||||
| ROCE % | -22.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5.08 | |||||
| Price-to-Tangible-Book | 5.15 | |||||
| EV-to-EBIT | -22.74 | |||||
| EV-to-EBITDA | -22.74 | |||||
| EV-to-FCF | -14.46 | |||||
| Price-to-Net-Current-Asset-Value | 11.01 | |||||
| Price-to-Net-Cash | 11.32 | |||||
| Earnings Yield (Greenblatt) % | -4.4 | |||||
| FCF Yield % | -5.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Luzhu Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -1.367 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 84.3 | ||
| 14-Day ATR (HK$) | 1.06275 | ||
| 20-Day SMA (HK$) | 20.555 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (HK$) | 16.14 - 42 | ||
| Shares Outstanding (Mil) | 262.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Luzhu Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Luzhu Biotechnology Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Luzhu Biotechnology Co Ltd Frequently Asked Questions
What is Beijing Luzhu Biotechnology Co Ltd(HKSE:02480)'s stock price today?
The current price of HKSE:02480 is HK$28.30. The 52 week high of HKSE:02480 is HK$42.00 and 52 week low is HK$16.14.
When is next earnings date of Beijing Luzhu Biotechnology Co Ltd(HKSE:02480)?
The next earnings date of Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) is .
Does Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) pay dividends? If so, how much?
Beijing Luzhu Biotechnology Co Ltd(HKSE:02480) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers